Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GSK25 is an inhibitor of Rho-associated kinase 1 (ROCK1; IC50 = 7 nM for the human kinase).1 It is selective for ROCK1 over p90 ribosomal S6 kinase 1 (RSK1) and p70 ribosomal S6 kinase (p70S6K; IC50s = 398 and 1,000 nM, respectively) and is greater than 100-fold selective over a panel of 31 additional kinases. GSK25 induces relaxation in precontracted isolated rat aortic rings (EC50 = 256 nM). In vivo, GSK25 (30 mg/kg) decreases mean arterial blood pressure in spontaneously hypertensive rats.
WARNING This product is not for human or veterinary use.
1. Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases. J. Med. Chem. 51(21), 6631-6634 (2008).